Evanko Jillian C.
Known title: DirectorCIK: 0001699043
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Parker-Hannifin Shows Aerospace Strength Ahead of Shareholder Meeting. Recent coverage notes that strong performance in PH’s aerospace systems segment is supporting recent price momentum. Analysts at TD Cowen kept a neutral stance but lifted their price target to $950, while Citi listed the company among leading electrical‑equipment stocks ahead of earnings season. The company will webcast its annual shareholders’ meeting on Oct. 28, 2026. These developments come as the stock trades near its long‑term support level.
Transaction History
| GEF | ▲ Buy | Grant | 2,143 | $0 | 2/23/2026 | View on chart |
| GEF | ▲ Buy | Grant | 2,668 | $0 | 2/24/2025 | View on chart |
| GEF | ▲ Buy | Grant | 1,465 | $0 | 6/4/2024 | View on chart |
| PH | ▲ Buy | Grant | 453 | $0 | 10/25/2023 | View on chart |
| PH | ▲ Buy | Grant | 653 | $0 | 10/26/2022 | View on chart |
| PH | ▲ Buy | Grant | 556 | $0 | 10/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Raymond James Upgrades Greif to Outperform with $90 Target
Raymond James upgraded Greif to Outperform and set a price target of $90. This follows Truist Securities maintaining a Hold rating while lowering its target to $94. Additionally, the company's emissions reduction targets were validated by the Science Based Targets initiative. These developments provide a mix of analyst perspectives and sustainability milestones for the stock.
Raymond James Upgrades Greif to Outperform with $90 Target. Raymond James upgraded Greif to Outperform and set a price target of $90. This follows Truist Securities maintaining a Hold rating while lowering its target to $94. Additionally, the company's emissions reduction targets were validated by the Science Based Targets initiative. These developments provide a mix of analyst perspectives and sustainability milestones for the stock.